Research Article

Assessment of Demodex Sp. Prevalence in Blepharitis Patients: Comparison of Light and Fluorescence Microscopy Techniques

Volume: 47 Number: 3 September 30, 2025
TR EN

Assessment of Demodex Sp. Prevalence in Blepharitis Patients: Comparison of Light and Fluorescence Microscopy Techniques

Abstract

Objective Demodex mites, the most prevalent human ectoparasites, are frequently associated with blepharitis. Despite their widespread occurrence, Demodex blepharitis remains underdiagnosed and often overlooked in clinical practice. This study investigates the prevalence and density of Demodex species in blepharitis patients, compares the diagnostic effectiveness of light and fluorescence microscopy, and examines the relationship between Demodex infestation and associated clinical symptoms. Methods A total of 240 people, 120 patients with blepharitis and 120 controls, were included in the study. Eyelash samples from both groups were analyzed using light microscopy and fluorescence microscopy to detect Demodex mites. Additionally, clinical and demographic data were gathered through a structured questionnaire. Results Demodex spp. were detected in 79.2% (95/120) of blepharitis patients by light microscopy and in 80.8% (97/120) by fluorescence microscopy. The prevalence of Demodex spp. was significantly higher in patients with blepharitis compared to controls (p<0.001). Fluorescent microscopy exhibited a higher detection rate than light microscopy (p=0.012). Conclusions Demodex mites play a significant role in ocular disorders, particularly blepharitis. Timely and accurate diagnosis, along with appropriate treatment, is essential to prevent the adverse mental and physical health impacts associated with Demodex blepharitis.

Keywords

Ethical Statement

This study was approved by Ethics Committee of Health Science University, Ankara Training and Research Hospital, Noninvasive Clinic Ethics Committee (Approval date: 05.12.2019; Number: E-19/127)

References

  1. 1. Elston CA, Elston DM. Demodex mites. Clin Dermatol. 2014;32(6):739-743. DOI: 10.1016/j.clindermatol.2014.02.012.
  2. 2. Erdal B, Albayrak H. Investigation of the prevalence of Demodex spp. in dermatological diseases. Turkiye Parazitol Derg. 2022;46(1):54-59. DOI: 10.4274/tpd.galenos.2021.93685.
  3. 3. Rather PA, Hassan I. Human Demodex mite: The versatile mite of dermatological importance. Indian J Dermatol. 2014;59(1):60-66. DOI: 10.4103/0019-5154.123498.
  4. 4. Rusiecka-Ziółkowska J, Nokiel M, Fleischer M. Demodex - an old pathogen or a new one? Adv Clin Exp Med. 2014;23(2):295-298. DOI: 10.17219/acem/37081.
  5. 5. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. DOI: 10.2147/OPTO.S142708.
  6. 6. Wesolowska M, Knysz B, Reich A, Blazejewska D, Czarnecki M, Gladysz A, Pozowski A, et al. Prevalence of Demodex spp. in eyelash follicles in different populations. Arch Med Sci. 2014;10(2):319-324. DOI: 10.5114/aoms.2014.42585.
  7. 7. Lacey N, Kavanagh K, Tseng SC. Under the lash: Demodex mites in human diseases. Biochem (Lond). 2009;31(4):2-6.
  8. 8. Liu J, Sheha H, Tseng SC. Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol. 2010;10(5):505-510. DOI: 10.1097/ACI.0b013e32833df9f4

Details

Primary Language

English

Subjects

Health Management , Health Services and Systems (Other)

Journal Section

Research Article

Publication Date

September 30, 2025

Submission Date

December 18, 2024

Acceptance Date

September 12, 2025

Published in Issue

Year 2025 Volume: 47 Number: 3

AMA
1.Kocaağa M, Demirel F, Şingar E, Karakoç AE. Assessment of Demodex Sp. Prevalence in Blepharitis Patients: Comparison of Light and Fluorescence Microscopy Techniques. CMJ. 2025;47(3):3-9. https://izlik.org/JA24FJ87GY